Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001192482-21-000194

Options or other derivatives

  • CFO & Treasurer acquired 500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Greenway Schond L. · CFO & Treasurer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-03-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +500,000 $3.73 2031-03-01 500,000 500,000 D
Loading xslF345X03/edgar.xml…